A robust reporter assay for the determination of the bioactivity of IL-4R-targeted therapeutic antibodies

Stokes, 2016, Characterization of asthma endotypes: implications for therapy, Ann. Allergy Asthma Immunol., 117, 121, 10.1016/j.anai.2016.05.016 Gibson, 2009, Inflammatory phenotypes in adult asthma: clinical applications, Clin. Respir. J., 3, 198, 10.1111/j.1752-699X.2009.00162.x Sokol, 2008, A mechanism for the initiation of allergen-induced T helper type 2 responses, Nat. Immunol., 9, 310, 10.1038/ni1558 Bagnasco, 2016, A critical evaluation of anti-IL-13 and anti-IL-4 strategies in severe asthma, Int. Arch. Allergy Immunol., 170, 122, 10.1159/000447692 Grey, 2019, Dupilumab in the treatment of asthma, Immunotherapy, 11, 859, 10.2217/imt-2019-0008 Xiong, 2019, Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials, Respir. Res., 20, 108, 10.1186/s12931-019-1065-3 Zayed, 2018, Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials, J. Asthma, 1 Barranco, 2017, Dupilumab in the management of moderate-to-severe asthma: the data so far, Ther. Clin. Risk Manag., 13, 1139, 10.2147/TCRM.S125964 Chung, 2016, Dupilumab: a potential new treatment for severe asthma, Lancet, 388, 3, 10.1016/S0140-6736(16)30311-7 Wenzel, 2013, Dupilumab in persistent asthma, N. Engl. J. Med., 369, 1276 Zhao, 2019, Important roles of CD32 in promoting suppression of IL-4 induced immune responses by a novel anti-IL-4Ralpha therapeutic antibody, mAbs, 11, 837, 10.1080/19420862.2019.1601985 Gassner, 2015, Development and validation of a novel SPR-based assay principle for bispecific molecules, J. Pharm. Biomed. Anal., 102, 144, 10.1016/j.jpba.2014.09.007 Tony, 1994, Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency, Eur. J. Biochem., 225, 659, 10.1111/j.1432-1033.1994.00659.x U.S. National Library of Medicine. https://clinicaltrials.gov/, 2021 (Accessed 1 March 2021). Michelini, 2010, Cell-based assays: fuelling drug discovery, Anal. Bioanal. Chem., 398, 227, 10.1007/s00216-010-3933-z Wang, 2020, Development of reporter gene assays to determine the bioactivity of biopharmaceuticals, Biotechnol. Adv., 39, 10.1016/j.biotechadv.2019.107466 Cheng, 2014, Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies, J. Immunol. Methods, 414, 69, 10.1016/j.jim.2014.07.010 Fu, 2018, Development of a robust reporter gene based assay for the bioactivity determination of IL-5-targeted therapeutic antibodies, J. Pharm. Biomed. Anal., 148, 280, 10.1016/j.jpba.2017.09.032 Parekh, 2012, Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay, mAbs, 4, 310, 10.4161/mabs.19873 Wang, 2016, Development of a robust reporter-based assay for the bioactivity determination of anti-VEGF therapeutic antibodies, J. Pharm. Biomed. Anal., 125, 212, 10.1016/j.jpba.2016.03.042 Wang, 2020, Development of a robust reporter gene-based assay for the bioactivity determination of recombinant human follicle stimulating hormone (rhFSH) pharmaceutical products, J. Pharm. Biomed. Anal., 177, 10.1016/j.jpba.2019.112855 Yang, 2014, A novel reporter gene assay for recombinant human erythropoietin (rHuEPO) pharmaceutical products, J. Pharm. Biomed. Anal., 100, 316, 10.1016/j.jpba.2014.08.003 Yu, 2012, A novel bioassay for the activity determination of therapeutic human brain natriuretic peptide (BNP), PLoS One, 7, 10.1371/journal.pone.0049934 Oh, 2010, Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma, Eur. Respir. Rev., 19, 46, 10.1183/09059180.00007609 Antczak, 2016, Analysis of changes in expression of IL-4/IL-13/STAT6 pathway and correlation with the selected clinical parameters in patients with atopic asthma, Int. J. Immunopathol. Pharmacol., 29, 195, 10.1177/0394632015623794 Kabesch, 2006, IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma, J. Allergy Clin. Immunol., 117, 269, 10.1016/j.jaci.2005.10.024 Nofziger, 2011, STAT6 links IL-4/IL-13 stimulation with pendrin expression in asthma and chronic obstructive pulmonary disease, Clin. Pharmacol. Ther., 90, 399, 10.1038/clpt.2011.128 Gandhi, 2014, Dynamics and interaction of interleukin-4 receptor subunits in living cells, Biophys. J., 107, 2515, 10.1016/j.bpj.2014.07.077 Nelms, 1999, The IL-4 receptor: signaling mechanisms and biologic functions, Annu. Rev. Immunol., 17, 701, 10.1146/annurev.immunol.17.1.701